News & Updates
Filter by Specialty:
Evolocumab safety, efficacy affirmed in Arabic patients
PCSK9 inhibition with evolocumab produces clinically meaningful and sustained reductions in certain lipid parameters in a predominantly Arabic population of individuals with familial hypercholesterolaemia (FH) and other non-FH indications, according to a study.
Evolocumab safety, efficacy affirmed in Arabic patients
23 Sep 2022DANFLU-1: High-dose quadrivalent flu vax reduces hospitalization, death in older adults
Older adults who receive a high-dose quadrivalent influenza vaccine have a 49 percent reduced risk of death and a 64 percent reduced risk of hospitalization for influenza or pneumonia compared with those who receive a standard-dose vaccine, results of the DANFLU-1 study showed.
DANFLU-1: High-dose quadrivalent flu vax reduces hospitalization, death in older adults
22 Sep 2022PDE5-I use poses no excess cardiovascular, mortality risk in diabetic men with ED
The presence of erectile dysfunction (ED) does not appear to confer an increased risk of cardiovascular disease (CVD) and mortality in men with diabetes mellitus (DM), with comparable risk of adverse cardiovascular events among users and nonusers of phosphodiesterase-5 inhibitors (PDE5-Is), which are used to manage ED, according to a study.
PDE5-I use poses no excess cardiovascular, mortality risk in diabetic men with ED
20 Sep 2022Chinese heart-healthy diet effective for lowering BP in Chinese adults
The cuisine-based Chinese heart-healthy (CHH) diet was effective, palatable, and cost-effective in reducing blood pressure (BP) in Chinese adults with mild hypertension, findings from the DECIDE*-Diet trial suggest.
Chinese heart-healthy diet effective for lowering BP in Chinese adults
19 Sep 2022SGLT2 inhibitors help prevent new-onset AF in diabetic Asians
Use of sodium-glucose cotransporter 2 inhibitors (SGLT2is) may reduce the risk of new-onset atrial fibrillation (AF) relative to glucagon-like peptide-1 receptor agonists (GLP-1RAs) in Asian patients with type 2 diabetes mellitus (T2DM) in a real-world practice, reports a recent study.